Abstract
Two distinct forms of malignant lymphomas can invade the central nervous system (CNS). Although primary CNS malignant lymphomas (PCNSMLs) invade the brain parenchyma, intravascular lymphomas (IVLs) form tumor cell aggregates in the vasculature and produce stroke-like symptoms and cognitive impairment. Although the tumor cells are mostly of B-cell origin in both types of lymphoma, their biological behavior is different, and the detailed mechanism(s) underlying this difference are not well understood. We studied the expression level of the adhesion molecules intercellular adhesion molecule-1 (ICAM-1) and integrin-β1 in tumor tissue samples from patients with primary CNS lymphoma (n = 8) and intravascular lymphoma (n = 2) using immunohistochemical analysis. We also assessed the expression of the matrix metalloproteinases (MMP)-2 and MMP-9. ICAM-1 was positive in six and integrin-β1 was positive in seven patients among eight PCNSML patients. MMP-2 and MMP-9 were expressed in all PCNSML. In contrast, none of them was positive in both IVL cases. Our findings suggest that adhesion molecules and MMPs are essential for malignant lymphoma cell invasion from the vasculature into the brain parenchyma and that they may be the key determinants for malignant lymphoma cells to behave as PCNSML or IVL cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Batchelor T, Loeffler JS (2006) Primary CNS lymphoma. J Clin Oncol 24:1281–1288
Hochberg FH, Baehring JM, Hochberg EP (2007) Primary CNS lymphoma. Nat Clin Pract Neurol 3:24–35
Hiraga S, Arita N, Ohnishi T, et al (1999) Rapid infusion of highdose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 91:221–230
Ferry JA, Harris NL, Picker LJ, et al (1988) Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors. Mod Pathol 1:444–452
Wick MR, Mills SE (1991) Intravascular lymphomatosis: clinicopathologic features and differential diagnosis. Semin Diagn Pathol 8:91–101
Baehring JM, Henchcliffe C, Ledezma CJ, et al (2005) Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system. J Neurol Neurosurg Psychiatry 76:540–544
Baehring JM, Longtine J, Hochberg FH (2003) A new approach to the diagnosis and treatment of intravascular lymphoma. J Neurooncol 61:237–248
Stefanidakis M, Koivunen E (2006) Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 108: 1441–1450
Chu PG, Arber DA (2001) CD79: a review. Appl Immunohistochem Mol Morphol 9:97–106
Weiss LM, Arber DA, Strickler JG (1994) Nasal T-cell lymphoma. Ann Oncol 5(suppl 1):39–42
Bashir R, Coakham H, Hochberg F (1992) Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain. J Neurooncol 12:103–110
Ponzoni M, Arrigoni G, Gould VE, et al (2000) Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 31:220–226
Tews DS, Nissen A (1998) Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors. Invasion Metastasis 18:271–284
Sood RR, Taheri S, Candelario-Jalil E, et al (2008) Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab 28:431–438
Yang Y, Estrada EY, Thompson JF, et al (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27:697–709
Jalkanen S, Aho R, Kallajoki M, et al (1989) Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis. Int J Cancer 44:777–782
Hazar B, Polat G, Seyrek E, et al (2004) Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin’s and non-Hodgkin’s lymphoma. Int J Clin Pract 58:139–143
Sakata K, Satoh M, Someya M, et al (2004) Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma. Cancer (Phila) 100:356–365
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kinoshita, M., Izumoto, S., Hashimoto, N. et al. Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomas. Brain Tumor Pathol 25, 73–78 (2008). https://doi.org/10.1007/s10014-008-0232-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10014-008-0232-x